Orphanse Healthcare is a drug company focusing on development of novel therapeutics in Emergency Care & Rescue Therapy. Our aim is to provide to healthcare professionals & patients with oromucosal treatments addressing significant unmet medical needs.
Orphanse Healthcare pipeline is composed by differentiated products with rapid development program.
Following EMA's Scientific Advice, our pilot program, ORH-01 enters into clinical phase in Q2-2018 with expected submission in Q1-2020.
Company Details
- Employees
- 4
- Founded
- -
- Address
- 60 Avenue Rockfeller, Lyon,rhone Alpes 69008,france
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://www.orphanse.com
- Keywords
- Brussels.
- HQ
- LYON, Rhone Alpes
Orphanse Healthcare Questions
Orphanse Healthcare's website is http://www.orphanse.com
Orphanse Healthcare's LinkedIn profile is https://fr.linkedin.com/company/orphanse-healthcare
Orphanse Healthcare has
4 employees.
View email and phone details for 4
employees at Orphanse Healthcare.
Orphanse Healthcare's industry is
Pharmaceutical Manufacturing
Orphanse Healthcare's top competitors are
Weber,
Ampleia,
Vivactis Group,
Gaoma Therapeutics,
Orphelia Pharma,
Enex Pharma,
Two Cents Agency,
Media4health,
Finpact,
Adocia.
Orphanse Healthcare's categories are Pharmaceutical Manufacturing
Orphanse Healthcare's founding year is 2015
